Delivery Order 75A50122D00004-75A50124F61011
Award Date
9/30/24
Potential Completion Date
3/14/25
Potential Value
$24K
Awardee
Seqirus Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Holly Springs, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus. The $2,130,454.55 firm fixed-price contract is for the storage and stability testing of antigen and adjuvant bulk lots and final containers. The work is to be performed at Seqirus' facility in Holly Springs, North Carolina. This delivery order is part of a larger $13.4 billion Indefinite Delivery...
This federal contract award was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $4,705.52 firm-fixed-price delivery order is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022 to provide a range of medical countermeasures and related services to support pandemic preparedness...
This federal contract award to Seqirus Inc., a division of CSL Seqirus, is for the H5N8 Short Term Physical Chemical Compatibility Study. The $42,351.55 firm-fixed-price purchase order was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) and did not have a set-aside designation. The contract is for services related to pandemic preparedness and response, including testing and storage of influenza vaccines and seed...
This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a global biotechnology company that develops life-saving medicines and vaccines. The $101,585.00 firm fixed-price delivery order is for storage and stability services related to pandemic preparedness and response, with the work to be performed at Seqirus' facility in Holly Springs, North Carolina....
This federal contract award to Seqirus Inc., a division of global biotechnology company CSL Seqirus, has a ceiling value of $1,904,213.20. The purpose of the contract is to provide medical countermeasures (MCMs), such as vaccines and adjuvants, for pandemic preparedness and response as required by the Department of Health and Human Services (HHS). Seqirus operates a manufacturing facility in Holly Springs, North Carolina and is a leading provider of MCMs to the U.S. federal government. The...
The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response awarded a $2.27 million firm fixed price delivery order to Seqirus Inc. under the company's Indefinite Delivery Indefinite Quantity contract number 75A50122D00004. The purpose of this task order is to procure services for storage and stability of antigens and adjuvants from prior contracts for the duration of base period year two. Seqirus Inc. will perform all work related to the...
This is a delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus. The $935,783.43 firm-fixed-price contract is for the provision of medical countermeasures, including vaccines, adjuvants, and related services, to support pandemic preparedness and response efforts. The work is being performed at Seqirus' facility in Holly Springs, North Carolina. This...
This contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The $28,513.00 firm fixed price purchase order is for resampling of HSN 1 monobulk antigen lots manufactured between 2006-2008. This work is performed at Seqirus' facility in Holly Springs, North Carolina. The contract does not have a set-aside designation. Seqirus is a...
This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The contract, valued at $34,163.00, is for the continuation of a physical chemical compatibility study of the H7N9 influenza vaccine with the MF59 adjuvant for an additional 18 months. The contract is a firm fixed-price purchase order with no set-aside...
This federal contract award to Seqirus Inc. was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The $402,112 firm fixed-price delivery order is for the acquisition of medical countermeasures (MCMs) for pandemic influenza preparedness and response, including the production, storage, and stability testing of...